Martha J. Demski was appointed to Teknova’s Board of Directors as an independent director in August 2023. Since 2005 she has also served on the board of Chimerix, Inc., where she was Chair from June 2018 through July 2023, and is currently the Lead Independent Director and a member of the audit committee. She also currently serves on the board of Equillium, Inc. as chair of the audit committee and a member of the compensation committee. Her prior board experience includes her role as director for several life sciences companies, including Adamas Pharmaceuticals, Inc., ADMA Biologics, Inc., and Neothetics, Inc.; she chaired the audit committee and was a member of the compensation committee of all three companies. From 2011 to 2017, Ms. Demski served as Senior Vice President and Chief Financial Officer of Ajinimoto Althea, Inc., now known as Ajinomoto Bio-Pharma Services, a fully integrated contract development and manufacturing organization. From 2008 to 2010, she served as the Interim Chief Operating Officer and Chief Financial Officer of the Sidney Kimmel Cancer Center, a non-profit corporation that engaged in biomedical research. Earlier, Ms. Demski served as Vice President and Chief Financial Officer of Vical. She has more than 13 years of banking experience with Bank of America.
Ms. Demski is a National Association of Corporate Directors Board Governance Fellow, and she received the Director of the Year in Corporate Governance award by the Corporate Directors Forum in 2017. Ms. Demski earned her B.A. from Michigan State University and an MBA from The University of Chicago Booth School of Business with concentrations in accounting and finance.